Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Review article: endocannabinoids and their receptors in the enteric nervous system
More is not always better with GLP-1 agonists
Continue for 812 weeks
Fractyl's approach specifically minimizes systemic exposure by targeting pancreatic beta cells and using a nutrient-responsive promoter rather than a constitutive one
Saxenda (Liraglutide 3 mg) Saxenda is a GLP-1 receptor agonist approved by the FDA in December 2014 for chronic weight management in adults with a BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity
US$ 21.24
US$ 25.24
US$ 22.96
US$ 20.37
US$ 26.73
US$ 20.84
US$ 23.67
US$ 25.62
US$ 29.92
